Shop
Showing 1–12 of 190 results
Discussion of the impact of Science in Japan caused by the “Millenium Project”, which was initiated by the former Japanese Prime Minister K. Obuchi in 1999 to vitializescience and technology of Japan.
Professor HirooImura, M.D., Ph.D.Foundation for Biomedical Research and Innovation at Kobe, Kyoto University
1. Recent advance in the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria (PNH)
Read moreDiscussion on the recent progress in the pathogenesis, diagnosis and treatment of Paroxysmal nocturnal hemoglobinuria (PNH).
Professor Yuzuru KANAKURA, M.D., Ph.D. The Department of Hematology and Oncology, Osaka University Graduate School of Medicine
Introduction of CD19-targeted CAR-T cell therapy approved by FDA in 2017 and progresses including application of genome editing technology to this novel therapy.
Professor Keiya Ozawa. Emeritus Professor and Visiting Professor Division of Immuno-Gene & Cell Therapy (Takara Bio)Jichi Medical University
Introduction of a research findings of JAK2V617F, CALR, and MPL mutations in patients suspected of Philadelphia-negative myeloproliferative neoplasm (MPN), as well as discussion on surrounding issues.
Professor Norio KOMATSU, M.D., Ph.D. Department of Hematology, Juntendo University School of Medicine
Summary of major advances of recent years in the field of MDS research, focusing on the results of the studies by Prof. Ogawa’s team.
Professor Seishi OGAWA, M.D., Ph.D.,Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University
Presentation of the history of the discovery of Regulatory T cells (Treg cells) along with the history of its function. The latter part of the lecture discusses the possibility of controlling immune response involving Treg cells from physiological and pathological perspectives.
Professor Shimon Sakaguchi, M.D., Ph.D.Immunology Frontier Research Center, Osaka University
Introduction of a study investigating a possible causative gene defect in the large Japanese family with inherited thrombophilia, as well as the discovery of a novel missense mutation in the prothombin gene (p.ARG596Leu) resulting in a variant prothrombin.
Professor Tetsuhito KOJIMA, M.D., Ph, D.Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine
Discussion of the current status and prospects of induced pluripotent stem cell (iPSC) based therapy for Parkinson’s Disease.
Professor Jun Takahashi, M.D., Ph.D.Center for iPS Cell Research and Application (CiRA), Kyoto University Department of Clinical Application
An overview of the recent progress and vision in the treatment of hemophilia including clinical trials on therapeutic drugs and gene therapy.
Professor Midori SHIMA, M.D., Ph, D.Department of Pediatrics, Nara Medical University
Discussion of clinical application of therapies using retinal pigment epithelium (RPE) generated from pluripotent stem cells (embryonic stem cells [ESC], iPSC), and its potential for global pharmaceutical and related businesses.
Project Leader Masayo Takahashi, M.D., Ph.D.Laboratory for Retinal Regeneration RIKEN
A Single Tube 10-Color Flow Cytometry Assay Optimizes Detection of Minimal Residual Disease in Chronic Lymphocytic Leukemia.
Read moreSartor MM, Gottlieb DJ.Sartor MM, Gottlieb DJ., Cytometry B Clinical Cytometry 2013; 84B: 96-103
